#BEGIN_DRUGCARD DB03779

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
44230

# Chemical_Formula:
C12H23NO10

# Chemical_IUPAC_Name:
(1R,2S,3s,4R,5S,6r)-6-{[(2R,3S,4S,5R,6S)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexane-1,2,3,4,5-pentol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Glucosaminyl-(Alpha-6)-D-Myo-Inositol

# HET_ID:
MYG

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C12H23NO10/c13-3-5(16)4(15)2(1-14)22-12(3)23-11-9(20)7(18)6(17)8(19)10(11)21/h2-12,14-21H,1,13H2/t2-,3-,4-,5-,6-,7-,8+,9+,10-,11-,12+/m0/s1

# InChI_Key:
InChIKey=HEPUIGACZYVUCD-JPGQGNGZSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3779

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
341.3117

# Molecular_Weight_Mono:
341.132195961

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1GYM

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.8

# Predicted_LogS:
0.05

# Predicted_Water_Solubility:
3.87e+02 g/l

# Primary_Accession_No:
DB03779

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936790

# PubChem_Substance_ID:
46508584

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02268

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
N[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@@H]1O[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:36 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Secreted protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M30809

# Drug_Target_1_GenBank_ID_Protein:
143340

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
>990 bp
ATGAGCAATAAGAAGTTAATTTTGAAATTATTCATATGTAGTACAATATTTATCACATTT
GTATTTGCTTTACATGATAAGAGAGTAGTTGCAGCTAGCTCTGTTAATGAGCTTGAAAAT
TGGTCAAAATGGATGCAACCTATACCTGATAGTATCCCGTTAGCACGAATTTCAATTCCA
GGAACACACGATAGTGGGACGTTCAAGTTGCAAAATCCGATTAAGCAAGTATGGGGAATG
ACGCAAGAATATGATTTTCGCTATCAAATGGACCATGGAGCTCGCATTTTTGATATAAGA
GGACGTTTAACAGATGATAATACGATAGTTCTTCATCATGGGCCATTATATCTTTACGTA
ACACTGCATGAATTCATAAATGAAGCGAAACAATTTTTAAAAGATAACCCGAGTGAAACA
ATTATTATGTCTTTAAAAAAAGAGTATGAGGATATGAAAGGGGCAGAAGATTCATTTAGT
AGCACGTTTGAAAAAAAATATTTTGTTGATCCTATTTTTTTAAAAACAGAAGGAAATATA
AAGCTTGGAGATGCTCGTGGGAAAATTGTACTACTAAAAAGATATAGTGGTAGTAATGAA
CCTGGAGGATATAATAATTTTTATTGGCCAGATAATGAGACGTTTACCACAACTGTAAAC
CAAAATGCAAATGTAACAGTACAAGATAAATATAAAGTGAGCTATGATGAGAAAGTAAAA
TCTATTAAAGATACGATGGATGAAACGATGAACAATAGCGAGGATTTAAATCATCTATAT
ATTAATTTTACAAGCTTGTCTTCTGGTGGTACAGCATGGAATAGTCCATATTACTATGCC
TCTTATATAAATCCTGAAATTGCAAACTATATAAAACAAAAGAATCCTGCGAGAGTAGGC
TGGGTAATTCAAGACTACATAAATGAAAAGTGGTCACCATTATTGTATCAAGAAGTTATA
AGAGCGAATAAGTCATTAATAAAAGAATAA

# Drug_Target_1_General_Function:
Involved in phospholipase C activity

# Drug_Target_1_General_References:
2509427	Kuppe A, Evans LM, McMillen DA, Griffith OH: Phosphatidylinositol-specific phospholipase C of Bacillus cereus: cloning, sequencing, and relationship to other phospholipases. J Bacteriol. 1989 Nov;171(11):6077-83.
7664726	Heinz DW, Ryan M, Bullock TL, Griffith OH: Crystal structure of the phosphatidylinositol-specific phospholipase C from Bacillus cereus in complex with myo-inositol. EMBO J. 1995 Aug 15;14(16):3855-63.
8755729	Heinz DW, Ryan M, Smith MP, Weaver LH, Keana JF, Griffith OH: Crystal structure of phosphatidylinositol-specific phospholipase C from Bacillus cereus in complex with glucosaminyl(alpha 1-->6)-D-myo-inositol, an essential fragment of GPI anchors. Biochemistry. 1996 Jul 23;35(29):9496-504.
9335537	Gassler CS, Ryan M, Liu T, Griffith OH, Heinz DW: Probing the roles of active site residues in phosphatidylinositol-specific phospholipase C from Bacillus cereus by site-directed mutagenesis. Biochemistry. 1997 Oct 21;36(42):12802-13.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3562

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
38110

# Drug_Target_1_Name:
1-phosphatidylinositol phosphodiesterase

# Drug_Target_1_Number_of_Residues:
329

# Drug_Target_1_PDB_ID:
1PTG

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00388	PI-PLC-X

# Drug_Target_1_Protein_Sequence:
>1-phosphatidylinositol phosphodiesterase precursor
MSNKKLILKLFICSTIFITFVFALHDKRVVAASSVNELENWSKWMQPIPDSIPLARISIP
GTHDSGTFKLQNPIKQVWGMTQEYDFRYQMDHGARIFDIRGRLTDDNTIVLHHGPLYLYV
TLHEFINEAKQFLKDNPSETIIMSLKKEYEDMKGAEDSFSSTFEKKYFVDPIFLKTEGNI
KLGDARGKIVLLKRYSGSNEPGGYNNFYWPDNETFTTTVNQNANVTVQDKYKVSYDEKVK
SIKDTMDETMNNSEDLNHLYINFTSLSSGGTAWNSPYYYASYINPEIANYIKQKNPARVG
WVIQDYINEKWSPLLYQEVIRANKSLIKE

# Drug_Target_1_Reaction:
1-phosphatidyl-1D-myo-inositol = 1D-myo-inositol 1,2-cyclic phosphate + 1,2-diacyl-sn-glycerol

# Drug_Target_1_Signals:
1-31

# Drug_Target_1_Specific_Function:
Cleaves glycosylphosphatidylinositol (GPI) and phosphatidylinositol (PI) anchors but not PI phosphates

# Drug_Target_1_SwissProt_ID:
P14262

# Drug_Target_1_SwissProt_Name:
PLC_BACCE

# Drug_Target_1_Synonyms:
1-phosphatidylinositol phosphodiesterase precursor
EC 4.6.1.13
PI-PLC
Phosphatidylinositol diacylglycerol-lyase
Phosphatidylinositol- specific phospholipase C

# Drug_Target_1_Theoretical_pI:
6.90

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB03779
